Evidence for the protective benefits of cannabidiol (CBD), the non-psychoactive plant cannabinoid produced by the cannabis plant, is quickly mounting up. Studies have found that CBD can influence myriad metabolic and immune processes, and that long-term dietary use may bring many important benefits.
Orally-administered CBD has been shown to exert a neuroprotective effect against ischemic stroke (a form of stroke caused by obstructed blood vessels in the brain), Alzheimer’s disease and Parkinson’s disease. There is also some evidence that CBD could confer an advantage in schizophrenics, while THC alone may exacerbate some symptoms of the disease. In the above study, THC alone was shown to be associated with more severe schizophrenic symptoms than THC combined with CBD.